Geode Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
1,316,341
-118,920
-8% -$84.7K ﹤0.01% 3349
2026
Q1
$657K Buy
1,435,261
+171,406
+14% +$158K ﹤0.01% 3488
2025
Q4
$2.78M Buy
1,263,855
+968,907
+329% +$1.56M ﹤0.01% 3046
2025
Q3
$469K Buy
294,948
+184,464
+167% +$239K ﹤0.01% 3647
2025
Q2
$179K Sell
110,484
-404,971
-79% -$654K ﹤0.01% 3908
2025
Q1
$613K Buy
515,455
+2,376
+0.5% +$3.79K ﹤0.01% 3472
2024
Q4
$1.06M Buy
513,079
+11,603
+2% +$27K ﹤0.01% 3358
2024
Q3
$1.27M Buy
501,476
+313,335
+167% +$1.02M ﹤0.01% 3274
2024
Q2
$803K Buy
188,141
+90,714
+93% +$584K ﹤0.01% 3393
2024
Q1
$721K Buy
+97,427
New +$820K ﹤0.01% 3483

Other funds holding GUTS

Geode Capital Management's GUTS Position: Q2 2026 in Review

Geode Capital Management reduced its Fractyl Health (GUTS) stake by 8.3% in Q2 2026, selling an estimated $84.7K and leaving 1,316,341 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

Geode Capital Management first reported a position in GUTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.78M in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Geode Capital Management held 1,316,341 shares of Fractyl Health worth $1.05M as of Q2 2026.
  • Geode Capital Management sold 118,920 Fractyl Health shares in Q2 2026, an estimated $84.7K.
  • Fractyl Health made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3349 holding.
  • Geode Capital Management first reported a position in Fractyl Health in Q1 2024 and has held it in 10 quarters since.
  • Geode Capital Management's Fractyl Health position peaked at $2.78M in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.